Products & Services · Revenue

Instruments — Revenue

ALMR Instruments — Revenue increased by 78.0% to $7.38M in Q1 2026 compared to the prior quarter. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2025
Last reportedQ1 2026
Rolls up toTotal Revenue

How to read this metric

An increase indicates growing market adoption of the company's hardware platform and expansion of the installed base, while a decrease may signal market saturation, increased competition, or delays in capital equipment procurement by customers.

Detailed definition

This metric represents the total revenue recognized from the sale or lease of proprietary proteomics instrumentation sys...

Peer comparison

Comparable to 'Instrument Revenue' or 'Systems Revenue' reported by life science tools and diagnostics companies that utilize a razor-and-blade business model.

Metric ID: almr_segment_instruments_revenue_from_contract_with_customer_excluding_assessed_tax

Historical Data

2 periods
 Q1 '25Q1 '26
Value$4.15M$7.38M
QoQ Change+78.0%
YoY Change+78.0%
Range$4.15M$7.38M
Avg YoY Growth+78.0%
Median YoY Growth+78.0%

Frequently Asked Questions

What is ALMR's instruments — revenue?
ALMR (ALMR) reported instruments — revenue of $7.38M in Q1 2026.
What does instruments — revenue mean?
Revenue generated specifically from the sale or leasing of the company's proteomics hardware instruments.